Autophagic regulation of cell growth by altered expression of Beclin 1 in triple-negative breast cancer

International Journal of Clinical and Experimental Medicine

Volumn 8, Issue 5, 2015, Pages 7049-7058

  Wang, Meng Chuan ^a   Wu, Ai Guo ^a   Huang, Yi Zhe ^a   Shao, Guo Li ^a   Ji, Shu Feng ^a   Wang, Ri Wei ^a   Yuan, Hong Jun ^a   Fan, Xu Long ^a   Zheng, Lin Hai ^a   Jiao, Qing Li ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Autophagy; Beclin 1 gene; Triple negative breast cancer

Indexed keywords

BECLIN 1; BETA CATENIN; NERVE CELL ADHESION MOLECULE; TRANSCRIPTION FACTOR SNAIL; UVOMORULIN; VIMENTIN;

ADULT; AGED; APOPTOSIS; ARTICLE; AUTOPHAGY; CANCER PROGNOSIS; CANCER SURVIVAL; CELL CYCLE; CELL GROWTH; CELL PROLIFERATION; CELL VIABILITY ASSAY; DISTANT METASTASIS; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE; PLASMID; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; SURVIVAL RATE; TRIPLE NEGATIVE BREAST CANCER; WESTERN BLOTTING;

EID: 84937037302     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. [1] Foulkes WD, Smith IE and Reis-Filho JS. Triple-negative breast cancer. N Engl J Med 2010; 36320: 1938-1948.
2. [2] Gucalp A and Traina TA. Triple-negative bre-ast cancer: adjuvant therapeutic options. Chemother Res Pract 2011; 2011: 696208.
3. [3] Cleator S, Heller W and Coombes RC. Triple-negative breast cancer: therapeutic options. Lancet Oncol 2007; 8: 235-244.
4. [4] Mizushima N, Yoshimori T and Levine B. Methods in mammalian autophagy research. Cell 2010; 140: 313-326.
5. [5] Dalby KN, Tekedereli I, Lopez-Berestein G and Ozpolat B. Targeting the prodeath and prosurvival functions of autophagy as novel therapeutic strategies in cancer. Autophagy 2010; 6: 322-329.
6. [6] Bhutia SK, Dash R, Das SK, Azab B, Su ZZ, Lee SG, Grant S, Yacoub A, Dent P, Curiel DT, Sarkar D and Fisher PB. Mechanism of autophagy to apoptosis switch triggered in prostate cancer cells by antitumor cytokine melanoma differentiation-associated gene 7/interleukin-24. Cancer Res 2010; 70: 3667-3676.
7. [7] White E and DiPaola RS. The double-edged sword of autophagy modulation in cancer. Clin Cancer Res 2009; 15: 5308-5316.
8. [8] John S, Nayvelt I, Hsu HC, Yang P, Liu W, Das GM, Thomas T and Thomas TJ. Regulation of estrogenic effects by Beclin 1 in breast cancer cells. Cancer Res 2008; 68: 7855-7863.
9. [9] Levine B and Kroemer G. Autophagy in the pathogenesis of disease. Cell 2008; 132: 27-42.
10. [10] Levine B. Cell biology: autophagy and cancer. Nature 2007; 446: 745-747.
11. [11] Qu X, Zou Z, Sun Q, Luby-Phelps K, Cheng P, Hogan RN, Gilpin C and Levine B. Autophagy gene-dependent clearance of apoptotic cells during embryonic development. Cell 2007; 128: 931-946.
12. [12] Yue Z, Jin S, Yang C, Levine AJ and Heintz N. Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor. Proc Natl Acad Sci U S A 2003; 100: 15077-15082.
13. [13] Kroemer G and Levine B. Autophagic cell death: the story of a misnomer. Nat Rev Mol Cell Biol 2008; 9: 1004-1010.
14. [14] Liang XH, Jackson S, Seaman M, Brown K, Kempkes B, Hibshoosh H and Levine B. Induction of autophagy and inhibition of tumorigenesis by Beclin 1. Nature 1999; 402: 672-676.
15. [15] Aita VM, Liang XH, Murty VV, Pincus DL, Yu W, Cayanis E, Kalachikov S, Gilliam TC and Levine B. Cloning and genomic organization of Beclin 1, a candidate tumor suppressor gene on chromosome 17q21. Genomics 1999; 59: 59-65.
16. [16] Negri T, Tarantino E, Orsenigo M, Reid JF, Gariboldi M, Zambetti M, Pierotti MA and Pilotti S. Chromosome band 17q21 in breast cancer: significant association between Beclin 1 loss and HER2/NEU amplification. Genes Chromo-somes Cancer 2010; 49: 901-909.
17. [17] Vanderlaag K, Su Y, Frankel AE, Burghardt RC, Barhoumi R, Chadalapaka G, Jutooru I and Safe S. 1,1-Bis(3’-indolyl)-1-(p-substituted phenyl) methanes induce autophagic cell death in estrogen receptor negative breast cancer. BMC Cancer 2010; 10: 669.
18. [18] Karantza-Wadsworth V and White E. Role of autophagy in breast cancer. Autophagy 2007; 3: 610-613.
19. [19] Li Z, Chen B, Wu Y, Jin F, Xia Y and Liu X. Genetic and epigenetic silencing of the Beclin 1 gene in sporadic breast tumors. BMC Cancer 2010; 10: 98.
20. [20] Wilson EN, Bristol ML, Di X, Maltese WA, Koterba K, Beckman MJ and Gewirtz DA. A switch between cytoprotective and cytotoxic autophagy in the radiosensitization of breast tumor cells by chloroquine and vitamin D. Horm Cancer 2011; 2: 272-285.
21. [21] Yang PM, Liu YL, Lin YC, Shun CT, Wu MS and Chen CC. Inhibition of autophagy enhances anticancer effects of atorvastatin in digestive malignancies. Cancer Res 2010; 70: 7699-7709.
22. [22] Moussay E, Kaoma T, Baginska J, Muller A, Van Moer K, Nicot N, Nazarov PV, Vallar L, Chouaib S, Berchem G and Janji B. The acquisition of resistance to TNF alpha in breast cancer cells is associated with constitutive activation of autophagy as revealed by a transcriptome analysis using a custom microarray. Autophagy 2011; 7: 760-770.
23. [23] Schoenlein PV, Periyasamy-Thandavan S, Samaddar JS, Jackson WH and Barrett JT. Autophagy facilitates the progression of ERalpha-positive breast cancer cells to antiestrogen resistance. Autophagy 2009; 5: 400-403.
24. [24] Esteve JM, Armengod ME and Knecht E. BRCA1 negatively regulates formation of autophagic vacuoles in MCF-7 breast cancer cells. Exp Cell Res 2010; 316: 2618-2629.
25. [25] Godbole AM, Purushottamachar P, Martin MS, Daskalakis C and Njar VC. Autophagy inhibition synergistically enhances anticancer efficacy of RAMBA, VN/12-1 in SKBR-3 cells, and tumor xenografts. Mol Cancer Ther 2012; 11: 898-908.
26. [26] de Medina P, Silvente-Poirot S and Poirot M. Tamoxifen and AEBS ligands induced apoptosis and autophagy in breast cancer cells through the stimulation of sterol accumulation. Autophagy 2009; 5: 1066-1067.
27. [27] Thomas S, Thurn KT, Biçaku E, Marchion DC and Münster PN. Addition of a histone deacetylase inhibitor redirects tamoxifen-treated breast cancer cells into apoptosis, which is opposed by the induction of autophagy. Breast Cancer Res Treat 2011; 130: 437-447.
28. [28] Akar U, Chaves-Reyez A, Barria M, Tari A, Sanguino A, Kondo Y, Kondo S, Arun B, Lopez-Berestein G and Ozpolat B. Silencing of Bcl-2 expression by small interfering RNA induces autophagic cell death in MCF-7 breast cancer cells. Autophagy 2008; 4: 669-679.